Trigone Pharma

Trigone Pharma is a clinical stage pharmaceutical company developing safe and effective local treatments for urinary tract diseases. Using our highly innovative delivery system for sustained release of drugs into the urinary bladder, the localized therapy acts continuously for up to several weeks, a revolution in urology. Trigone Pharma aims to restore the quality of life for patients suffering from bladder diseases with clear unmet medical need. The first product in development, for the treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), is in clinical trials. The second product in development, for the treatment for BCG-Refractory Non-Muscle Invasive Bladder Cancer (NMIBC) is in preclinical stage.